CCBot/2.0 (
We use cookies and third-party to provide a better experience and service. Following acceptance for use browsing.ContinueCookies policy


Dr. Juan Buades Reines
Internal medicine Specialist

Doctor Juan Buades Reines specialist in Medicina interna

NPI: 070701439

Expert in:

All treatments

Make an appointment View Telephone

Professional Statement

Renowned specialist in internal medicine, Dr. Buades Reines is a national reference in polyneuropathy Amiloidotica.Licenciado in Medicine and Surgery at the Faculty of Granada, specialist in Internal Medicine by MIR training in the Hospital de Cruces, he won the Outstanding Doctorate cum Laudem from the University of Barcelona in 1988. Lead researcher and contributor to numerous studies related to their specialty and scientific papers. She combines her clinical work with the release of their knowledge being editor of the magazine Balearic Medicine. In addition, he has authored five book chapters, 40 publications, 29 national and 11 international scope; He has made ​​60 communications and 38

Learn more

*Translated with Google translator. We apologize for any imperfection

BOOK AN APPOINTMENT with doctor Juan Buades Reines


Consulta Privada Dr. Buades Reines

Carrer de Cecili Metel, 4 - 1° A, 07003 Palma de Mallorca

No availability these days. Next: 27/10/2016 »
Medical insurance accepted : Consulta Privada (sin seguro médico)

First consultation : 150€

Follow-up consultation : 120€



Consulta Privada Dr. Buades Reines

Telephone : 9710... see more

Other information:


  • - More than 40 years of experience
  • - Professional experience
    1. • internist and Coordinator of the Working Group of amyloid polyneuropathy Llatzer Son Family Hospital (2011)
    2. • Chief of Internal Medicine and head of the medical area are Llatzer Hospital, by national competition (2001 - 2010)
    3. • Head of the Internal Medicine Hospital of Mallorca, on merit (1996 - 2001)
    4. • Chief of Internal Medicine Hospital Joan March, by open competition (1991 - 1996)
    5. • Deputy Internal Medicine at Hospital Son Dureta for Competition National Opposition (1978 - 1990)
    6. • Deputy Internal Medicine at the Hospital de Cruces, Competitive National Opposition (1977)
    7. • MIR specializing in Internal Medicine at the Hospital de Cruces (Bilbao) (1973-1977)
  • + Education
    1. • Bachelor of Medicine and Surgery at the Faculty of Granada (1972)
    2. • Specialist in Internal Medicine by MIR training in the Hospital de Cruces (1973 - 1977)
    3. • Excellent Cum Laudem PhD from the University of Barcelona (1988)
    4. • Principal investigator of "Multicenter Study of Familial Mediterranean Fever" (1988 -1990)
    5. • Participating in the study of Leishmania + HIV with treatment with interferon (1992)
    6. • Prospective participant in the sensitivity of Mycobacterium tuberculosis in HIV (+) and HIV (1993)
    7. • Participating in the study of the genetic makeup of the population "xueta" (Jews of Mallorca) and carrier detection of some diseases (1993)
    8. • Participating in the Study of the Jewish population of Mallorca at the level of mitochondrial DNA typing and familial Mediterranean fever in this population (1993)
    9. • Participant in the study of DNA in patients with Familial Mediterranean Fever (1996)
    10. • Participating in the study "Genetic characterization of patients with familial Mediterranean fever (FMF)" (1998)
    11. • Participating in the prospective and comparative study of teicoplanin versus vancomycin in the treatment of patients with infection associated with intravascular catheters (1998)
    12. • Participating in the study "Use of healthcare resources and costs associated with the diagnosis and treatment of polyneuropathy Amilidotica Family in Spain" (2011)
    13. • Participating in the "global, multicenter, longitudinal, observational study of patients with documented mutations amyloidosis Transthyretin (TTR) or wild-type TTR, Thaos" (2012)
    14. • Participant in "ALN-TTRO2-002 A Phase 2 Open-Label, multi-dose, dose escalation trial to Evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of intravenous infusions of ALN-TTR02 in Patients With TTR amyloidosis" (2013)
    15. • Principal investigator on "Study Extension Phase 3, multicenter, open, to assess the long-term safety, clinical activity and pharmacokinetics of ALN-TTR02 in patients with familial amyloid polyneuropathy who have previously been treated with ALN-TTR02. Laboratory Alnylam Boston, USA (2013)
    16. • principal investigator in the "non-interventionist cross-sectional study on the burden of disease (CDE) in patients with familial amyloid polyneuropathy associated with transthyretin (TTR-FAP) or cardiomyopathy associated with transthyretin (TTR-MC) and caregivers." PFIZER Laboratories (2013)
    17. • APOLLO study principal investigator of the Phase 3, randomized, double-blind, placebo-controlled, multicenter, multinational to evaluate the efficacy and safety. ALN-TTRO2. In polyneuropathy measured by transthyretin (TTR-FAP). Alnylam laboratory Boston, USA (2014)
  • + Publications and conferences
    1. • Medicine magazine editor Balear (present)
    2. • Author of five book chapters, 40 publications (29 national and international 11)
    3. • 60 communications to congresses and meetings and 38 conferences
    4. Publications in the National Institute of Health
  • + Recognition and awards
    1. • Hadassah International Prize, awarded by Hadassah Medical Relief (Israel) (1988)
    2. • FISS grant for "multicenter study of Familial Mediterranean Fever" (1988 - 1990)
  • + Professional membership
    1. • Academician of the Royal Academy of Medicine and Surgery of the Balearic Islands (1999)
  • - Languages spoken
    1. • Spanish

*Translated with Google translator. We apologize for any imperfection

Source: All information contained on this page as well as office hours available, are provided directly by the doctor who has the ability to update them at all times in order to keep the information as accurate as possible.